KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Inventory (2016 - 2025)

Historic Inventory for Exact Sciences (EXAS) over the last 12 years, with Q4 2025 value amounting to $166.2 million.

  • Exact Sciences' Inventory rose 235.12% to $166.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $166.2 million, marking a year-over-year increase of 235.12%. This contributed to the annual value of $166.2 million for FY2025, which is 235.12% up from last year.
  • Exact Sciences' Inventory amounted to $166.2 million in Q4 2025, which was up 235.12% from $164.8 million recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' Inventory registered a high of $176.6 million during Q1 2025, and its lowest value of $89.0 million during Q1 2021.
  • In the last 5 years, Exact Sciences' Inventory had a median value of $127.4 million in 2023 and averaged $129.5 million.
  • In the last 5 years, Exact Sciences' Inventory tumbled by 259.77% in 2024 and then skyrocketed by 3737.53% in 2025.
  • Over the past 5 years, Exact Sciences' Inventory (Quarter) stood at $105.0 million in 2021, then rose by 12.63% to $118.3 million in 2022, then grew by 7.79% to $127.5 million in 2023, then grew by 27.38% to $162.4 million in 2024, then rose by 2.35% to $166.2 million in 2025.
  • Its last three reported values are $166.2 million in Q4 2025, $164.8 million for Q3 2025, and $171.5 million during Q2 2025.